Expertise in
19
conditions

Dr. Daniel J. Canter

Urology
Georgia Urology Sandy Springs
5730 Glenridge Dr, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Expertise in
19
conditions
Georgia Urology Sandy Springs
5730 Glenridge Dr, 
Atlanta, GA 

Overview

Daniel Canter is a Urologist practicing medicine in Atlanta, Georgia.

Dr. Canter is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy.

He is actively involved in clinical research, co-authoring 102 peer reviewed articles and participating in 5 clinical trials. Dr. Canter is currently accepting new patients.

Specialties

Urology

Licenses

Urology in PA

Hospital Affiliations

Northside Hospital Forsyth
Northside Hospital Cherokee
Northside Hospital Gwinnett
Northside Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Georgia Urology Sandy Springs
5730 Glenridge Dr, Atlanta, GA 30328

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 23, 2026
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drugs: ALT-803, Bacillus Calumette-Guerin
Study Phase: Phase 2/Phase 3
Long-Term Prospective Registry to Evaluate Treatment Decisions and Clinical Outcomes in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
Long-Term Prospective Registry to Evaluate Treatment Decisions and Clinical Outcomes in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
Enrollment Status: Active_not_recruiting
Publish Date: July 14, 2025
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other
Study Phase: Phase 3
View 4 Less Clinical Trials

102 Total Publications

Colonic Metastasis of Renal Cell Carcinoma: A Rare Cause of Lower Gastrointestinal Bleeding.
Colonic Metastasis of Renal Cell Carcinoma: A Rare Cause of Lower Gastrointestinal Bleeding.
Journal: Cureus
Published: August 26, 2025
Similar Doctors
Expertise in
26
conditions
Expertise in
26
conditions
Referral required
Before you request

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (8.4 miles away)
404-778-4898
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Viraj Master is a Urologist practicing medicine in Atlanta, Georgia. Dr. Master is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Penile Cancer, Prostate Cancer, Nephrectomy, and Lymphadenectomy. Dr. Master is board certified in American Board Of Urology, 2006. Dr. Master is currently accepting new patients.

Expertise in
37
conditions
Expertise in
37
conditions
Referral may be required
Before you request

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (8.4 miles away)
404-778-4898
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth Ogan is a Urologist practicing medicine in Atlanta, Georgia. Dr. Ogan is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Ureterocele, Clear Cell Sarcoma, Nephrectomy, and Ureteroscopy. Dr. Ogan is board certified in American Board Of Urology, 2004. Dr. Ogan is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required
Before you request

Emory Saint Joseph's Hospital Campus

5673 Peachtree Dunwoody Road, Ste350A, 
Atlanta, GA 
 (0.7 miles away)
404-778-4898
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Pattaras is a Urologist practicing medicine in Atlanta, Georgia. Dr. Pattaras is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Ureterocele, Prostate Cancer, Nephrectomy, and Cystectomy. Dr. Pattaras is board certified in American Board Of Urology, 2002. Dr. Pattaras is currently accepting new patients.

Frequently Asked Questions about Dr. Daniel J. Canter

How do I make an appointment with Dr. Daniel J. Canter?

You can book an appointment with Dr. Daniel J. Canter by calling their office at 404-256-1844. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Daniel J. Canter a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel J. Canter is classified as an Distinguished expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Daniel J. Canter specialize in?

While Dr. Daniel J. Canter is a Urology, they have specific expertise in Bladder Cancer, Nephrectomy, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Daniel J. Canter participate in research or clinical trials?

Yes. Dr. Daniel J. Canter has published 102 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Daniel J. Canter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Daniel J. Canter accept my insurance?

Dr. Daniel J. Canter accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 404-256-1844 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Canter's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 12 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile